These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 10844936

  • 1. Genetic, biochemical, and clinical features of chronic granulomatous disease.
    Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM.
    Medicine (Baltimore); 2000 May; 79(3):170-200. PubMed ID: 10844936
    [Abstract] [Full Text] [Related]

  • 2. The molecular basis of chronic granulomatous disease.
    Meischl C, Roos D.
    Springer Semin Immunopathol; 1998 May; 19(4):417-34. PubMed ID: 9618766
    [Abstract] [Full Text] [Related]

  • 3. Intersecting Stories of the Phagocyte NADPH Oxidase and Chronic Granulomatous Disease.
    Nauseef WM, Clark RA.
    Methods Mol Biol; 2019 May; 1982():3-16. PubMed ID: 31172463
    [Abstract] [Full Text] [Related]

  • 4. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism.
    Vignais PV.
    Cell Mol Life Sci; 2002 Sep; 59(9):1428-59. PubMed ID: 12440767
    [Abstract] [Full Text] [Related]

  • 5. The p47phox mouse knock-out model of chronic granulomatous disease.
    Jackson SH, Gallin JI, Holland SM.
    J Exp Med; 1995 Sep 01; 182(3):751-8. PubMed ID: 7650482
    [Abstract] [Full Text] [Related]

  • 6. Involvement of p40phox in activation of phagocyte NADPH oxidase through association of its carboxyl-terminal, but not its amino-terminal, with p67phox.
    Tsunawaki S, Kagara S, Yoshikawa K, Yoshida LS, Kuratsuji T, Namiki H.
    J Exp Med; 1996 Sep 01; 184(3):893-902. PubMed ID: 9064349
    [Abstract] [Full Text] [Related]

  • 7. Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.
    Okura Y, Yamada M, Kuribayashi F, Kobayashi I, Ariga T.
    J Clin Immunol; 2015 Feb 01; 35(2):158-67. PubMed ID: 25666294
    [Abstract] [Full Text] [Related]

  • 8. Chronic Granulomatous Disease.
    Roos D.
    Methods Mol Biol; 2019 Feb 01; 1982():531-542. PubMed ID: 31172494
    [Abstract] [Full Text] [Related]

  • 9. [Molecular aspects of chronic granulomatous disease. "the NADPH oxidase complex"].
    Morel F.
    Bull Acad Natl Med; 2007 Feb 01; 191(2):377-90; discussion 390-2. PubMed ID: 17969555
    [Abstract] [Full Text] [Related]

  • 10. [The X+ chronic granulomatous disease as a fabulous model to study the NADPH oxidase complex activation].
    Stasia MJ.
    Med Sci (Paris); 2007 May 01; 23(5):526-32. PubMed ID: 17502070
    [Abstract] [Full Text] [Related]

  • 11. Rapid detection of intracellular p47phox and p67phox by flow cytometry; useful screening tests for chronic granulomatous disease.
    Wada T, Muraoka M, Toma T, Imai T, Shigemura T, Agematsu K, Haraguchi K, Moriuchi H, Oh-Ishi T, Kitoh T, Ohara O, Morio T, Yachie A.
    J Clin Immunol; 2013 May 01; 33(4):857-64. PubMed ID: 23306776
    [Abstract] [Full Text] [Related]

  • 12. NADPH oxidase.
    Shatwell KP, Segal AW.
    Int J Biochem Cell Biol; 1996 Nov 01; 28(11):1191-5. PubMed ID: 9022278
    [Abstract] [Full Text] [Related]

  • 13. Common Infections and Target Organs Associated with Chronic Granulomatous Disease in Iran.
    Mortaz E, Azempour E, Mansouri D, Tabarsi P, Ghazi M, Koenderman L, Roos D, Adcock IM.
    Int Arch Allergy Immunol; 2019 Nov 01; 179(1):62-73. PubMed ID: 30904913
    [Abstract] [Full Text] [Related]

  • 14. A Founder Effect of c.257 + 2T > C Mutation in NCF2 Gene Underlies Severe Chronic Granulomatous Disease in Eleven Patients.
    Ben-Farhat K, Ben-Mustapha I, Ben-Ali M, Rouault K, Hamami S, Mekki N, Ben-Chehida A, Larguèche B, Fitouri Z, Abdelmoula S, Khemiri M, Guediche MN, Boukthir S, Barsaoui S, Chemli J, Barbouche MR.
    J Clin Immunol; 2016 Aug 01; 36(6):547-54. PubMed ID: 27220316
    [Abstract] [Full Text] [Related]

  • 15. Chronic granulamatous disease: Two decades of experience from a paediatric immunology unit in a country with high rate of consangineous marriages.
    Kutukculer N, Aykut A, Karaca NE, Durmaz A, Aksu G, Genel F, Pariltay E, Cogulu Ö, Azarsız E.
    Scand J Immunol; 2019 Feb 01; 89(2):e12737. PubMed ID: 30506560
    [Abstract] [Full Text] [Related]

  • 16. Delineation of the phagocyte NADPH oxidase through studies of chronic granulomatous diseases of childhood.
    Gallin JI.
    Int J Tissue React; 1993 Feb 01; 15(3):99-103. PubMed ID: 8188451
    [Abstract] [Full Text] [Related]

  • 17. Gene therapy for chronic granulomatous disease.
    Barese CN, Goebel WS, Dinauer MC.
    Expert Opin Biol Ther; 2004 Sep 01; 4(9):1423-34. PubMed ID: 15335310
    [Abstract] [Full Text] [Related]

  • 18. The search for a genetic defect in Polish patients with chronic granulomatous disease.
    Jurkowska M, Kurenko-Deptuch M, Bal J, Roos D.
    Arch Immunol Ther Exp (Warsz); 2004 Sep 01; 52(6):441-6. PubMed ID: 15577746
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.